Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Neuropharmacology
|
April 21, 2020
Hippocampal synaptic dysfunction in the SOD1<sup>G93A</sup> mouse model of Amyotrophic Lateral Sclerosis: Reversal by adenosine A<sub>2A</sub>R blockade
N Rei, D M Rombo, M F Ferreira, et al.
Acta Physiologica (Oxford, England)
|
April 17, 2015
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus
B K Kishore, N G Carlson, C M Ecelbarger, et al.
Klinische Padiatrie
|
January 11, 2005
Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood
S M Schmidt, C E Müller, L Gürtler, et al.
Purinergic Signalling
|
November 9, 2017
Anti-inflammatory effect of a novel locally acting A<sub>2A</sub> receptor agonist in a rat model of oxazolone-induced colitis
L Antonioli, A El-Tayeb, C Pellegrini, et al.
Molecular Psychiatry
|
February 29, 2012
Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
V L Batalha, J M Pego, B M Fontinha, et al.
Neuroscience
|
January 26, 2010
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors
A M Farrar, K N Segovia, P A Randall, et al.
Neuroscience
|
July 23, 2013
The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor
S J Podurgiel, E J Nunes, S E Yohn, et al.
Molecular Psychiatry
|
December 3, 2014
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
C Laurent, S Burnouf, B Ferry, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Neuropharmacology
|
April 21, 2020
Hippocampal synaptic dysfunction in the SOD1<sup>G93A</sup> mouse model of Amyotrophic Lateral Sclerosis: Reversal by adenosine A<sub>2A</sub>R blockade
N Rei, D M Rombo, M F Ferreira, et al.
Acta Physiologica (Oxford, England)
|
April 17, 2015
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus
B K Kishore, N G Carlson, C M Ecelbarger, et al.
Klinische Padiatrie
|
January 11, 2005
Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood
S M Schmidt, C E Müller, L Gürtler, et al.
Purinergic Signalling
|
November 9, 2017
Anti-inflammatory effect of a novel locally acting A<sub>2A</sub> receptor agonist in a rat model of oxazolone-induced colitis
L Antonioli, A El-Tayeb, C Pellegrini, et al.
Molecular Psychiatry
|
February 29, 2012
Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
V L Batalha, J M Pego, B M Fontinha, et al.
Neuroscience
|
January 26, 2010
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors
A M Farrar, K N Segovia, P A Randall, et al.
Neuroscience
|
July 23, 2013
The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor
S J Podurgiel, E J Nunes, S E Yohn, et al.
Molecular Psychiatry
|
December 3, 2014
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
C Laurent, S Burnouf, B Ferry, et al.
Page
of 7